01 1Actemra
02 7Actemra/RoActemra
03 2Actemra/Roactemra
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 2,380
2018 Revenue in Millions : 2,225
Growth (%) : 7
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 3,184
2019 Revenue in Millions : 2,575
Growth (%) : 24
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 3,833
2020 Revenue in Millions : 3,029
Growth (%) : 25
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 2,953
2021 Revenue in Millions : 3,833
Growth (%) : -23
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 3,051
2022 Revenue in Millions : 2,953
Growth (%) : -3
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2014 Revenue in Millions : 18.00%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2015 Revenue in Millions : 1,236
2014 Revenue in Millions : 1,446
Growth (%) : 17%
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2016 Revenue in Millions : 1,680
2015 Revenue in Millions : 1,418
Growth (%) : 19
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2017 Revenue in Millions : 2,042
2016 Revenue in Millions : 1,799
Growth (%) : 13
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2018 Revenue in Millions : 2,182
2017 Revenue in Millions : 1,945
Growth (%) : 12%
LOOKING FOR A SUPPLIER?
